Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 5:18 pm Purchase | 2024-09-30 | 13G | Arch Therapeutics, Inc. ARTH | Bigger Capital LLC | 300,000 6.800% | 300,000 (New Position) | Filing History |
| 2024-01-22 12:39 pm Purchase | 2023-12-31 | 13G | Arch Therapeutics, Inc. ARTH | Parker Michael Andrew | 213,529 4.500% | 107,340 (+101.08%) | Filing History |
| 2023-08-09 11:16 am Purchase | 2023-07-12 | 13G | Arch Therapeutics, Inc. ARTH | Stahl Andrew | 300,000 9.890% | 300,000 (New Position) | Filing History |
| 2023-07-25 2:47 pm Purchase | 2023-07-12 | 13G | Arch Therapeutics, Inc. ARTH | wilson brandt | 300,000 9.890% | 300,000 (New Position) | Filing History |
| 2023-07-14 09:00 am Purchase | 2023-07-12 | 13G | Arch Therapeutics, Inc. ARTH | BIGGER CAPITAL FUND L P | 300,000 9.900% | 300,000 (New Position) | Filing History |
| 2023-07-12 5:00 pm Purchase | 2023-07-12 | 13G | Arch Therapeutics, Inc. ARTH | Oasis Capital LLC | 303,142 9.990% | 303,142 (New Position) | Filing History |
| 2023-01-27 2:18 pm Unchanged | 2022-12-31 | 13G | Arch Therapeutics, Inc. ARTH | Parker Michael Andrew | 106,189 8.497% | 0 (Unchanged) | Filing History |
| 2023-01-25 3:18 pm Purchase | 2022-12-31 | 13G | Arch Therapeutics, Inc. ARTH | Parker Michael Andrew | 106,189 8.497% | 106,189 (New Position) | Filing History |
| 2022-01-12 10:07 am Purchase | 2021-12-31 | 13G | Arch Therapeutics, Inc. ARTH | Parker Michael Andrew | 4,194,140,000 8.840% | 1,100,574,000 (+35.58%) | Filing History |
| 2021-01-22 5:27 pm Purchase | 2020-12-31 | 13G | Arch Therapeutics, Inc. ARTH | Parker Michael Andrew | 3,093,566,000 8.010% | 244,707,800 (+8.59%) | Filing History |
| 2020-01-23 12:24 pm Purchase | 2019-12-31 | 13G | Arch Therapeutics, Inc. ARTH | Parker Michael Andrew | 2,848,858,200 7.580% | 919,628,000 (+47.67%) | Filing History |